华润医药(03320)附属华润医药控股增持华润博雅生物股份比例达到1%

智通财经12-18

智通财经APP讯，华润医药(03320)公布，于2024年11月8日至2024年12月18日期间，公司全资附属公司华润医药控股透过深圳证券交易所交易系统的集中竞价交易累计收购华润博雅生物额外504.24万股股份，占华润博雅生物股本总额的1.00%。

截至本公告日期及于上述增持股份后，公司透过华润医药控股间接持有华润博雅生物总股本约30.28%及总股本约41.59%表决权。华润博雅生物作为该公司附属公司入账。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492018124?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-18 22:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492018124","market":"us","top_or_hot":-1,"title":"华润医药(03320)附属华润医药控股增持华润博雅生物股份比例达到1%","media":"智通财经","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/03320\">华润医药</a>(03320)公布，于2024年11月8日至2024年12月18日期间，公司全资附属公司华润医药控股透过深圳证券交易所交易系统的集中竞价交易累计收购华润<a href=\"https://laohu8.com/S/300294\">博雅生物</a>额外504.24万股股份，占华润博雅生物股本总额的1.00%。</p><p>截至本公告日期及于上述增持股份后，公司透过华润医药控股间接持有华润博雅生物总股本约30.28%及总股本约41.59%表决权。华润博雅生物作为该公司附属公司入账。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华润医药(03320)附属华润医药控股增持华润博雅生物股份比例达到1%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华润医药(03320)附属华润医药控股增持华润博雅生物股份比例达到1%\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经</strong><span class=\"h-time small\">2024-12-18 22:36</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/03320\">华润医药</a>(03320)公布，于2024年11月8日至2024年12月18日期间，公司全资附属公司华润医药控股透过深圳证券交易所交易系统的集中竞价交易累计收购华润<a href=\"https://laohu8.com/S/300294\">博雅生物</a>额外504.24万股股份，占华润博雅生物股本总额的1.00%。</p><p>截至本公告日期及于上述增持股份后，公司透过华润医药控股间接持有华润博雅生物总股本约30.28%及总股本约41.59%表决权。华润博雅生物作为该公司附属公司入账。</p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.zhitongcaijing.com/content/detail/1226794.html\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0197","symbol_name":"中小创蓝筹","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1226794.html","article_id":"2492018124","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492018124","pubTimestamp":1734532603,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，华润医药(03320)公布，于2024年11月8日至2024年12月18日期间，公司全资附属公司华润医药控股透过深圳证券交易所交易系统的集中竞价交易累计收购华润博雅生物额外504.24万股股份，占华润博雅生物股本总额的1.00%。截至本公告日期及于上述增持股份后，公司透过华润医药控股间接持有华润博雅生物总股本约30.28%及总股本约41.59%表决权。华润博雅生物作为该公司附属公司入账。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300294":"博雅生物","BK0197":"中小创蓝筹","03320":"华润医药","BK1191":"制药","BK1570":"华润系","BK0046":"生物疫苗","BK0239":"医药制造"},"translate_title":"China Resources Pharmaceutical (03320) subsidiary China Resources Pharmaceutical Holdings increased its shareholding in China Resources Boya Biotech to 1%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300294":1,"03320":1},"content_text":"智通财经APP讯，华润医药(03320)公布，于2024年11月8日至2024年12月18日期间，公司全资附属公司华润医药控股透过深圳证券交易所交易系统的集中竞价交易累计收购华润博雅生物额外504.24万股股份，占华润博雅生物股本总额的1.00%。截至本公告日期及于上述增持股份后，公司透过华润医药控股间接持有华润博雅生物总股本约30.28%及总股本约41.59%表决权。华润博雅生物作为该公司附属公司入账。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492018124"}